fda semaglutide ban on Compounded GLP-1 Drugs: What to Know The FDA Is Reconsidering Its

Peptide: Retatrutide 20mg Type: Longevity Brand: Bio Stem (For research purposes only) Retatrutide is known as a triple agonist, meaning it activates:GLP-1 receptors helps control appetite + slows digestionGIP receptors improves insulin response + nutrient handlingGlucagon receptors increases energy expenditure + fat burning Retatrutide is a multi-receptor agonist currently being studied for its interaction with metabolic pathways, including GLP-1, GIP, and glucagon receptors

Adaptogenic mushrooms may help reduce the effects of stress

Sanofi is hiring a Global Brand Lead for rilzabrutinib and a Rezurock Marketing Lead alongside three apprenticeships Weight management enters the global marketing conversation

Discover the benefits and risks of compounded medications in our latest blog

Ohio weight-loss clinics continue to be disciplined over alleged unsafe practices and false claims that they pass regulatory muster

CONTRIBUTED CONTENT You dont have to spend hours at the gym every day to fit back into those pre-pandemic jeans, and you dont have to starve yourself either